From 8545d91ff40ea0362be1fd985f298211bcf113da Mon Sep 17 00:00:00 2001
From: Isabell Alexandra Guckes <isabell.guckes@uni-bielefeld.de>
Date: Wed, 25 Sep 2024 18:27:34 +0000
Subject: [PATCH] Update file description.tsx
---
src/contents/description.tsx | 6 +++---
1 file changed, 3 insertions(+), 3 deletions(-)
diff --git a/src/contents/description.tsx b/src/contents/description.tsx
index 061cd536..f49037c4 100644
--- a/src/contents/description.tsx
+++ b/src/contents/description.tsx
@@ -110,13 +110,13 @@ export function Description() {
</div>
</Subesction>
<Subesction title="Treatment" id="Cystic Fibrosis6">
- <img src="https://static.igem.wiki/teams/5247/placeholders/placehilderperson.jpeg"/>
+ <p>Cystic fibrosis therapy means inevitably a complex and customized treatment plan for each patient. It consists of a range of components. These include medication such as CFTR modulators and antibiotics as well as inhalation therapy and mucolytics, physiotherapy, nutritional therapy and sports therapy. It is therefore essential that CF patients receive treatment at a specialist centre [1].</p>
<Collapsible id="drugs-collapsible" title="Different types of drugs" >
<TabButtonRow data={medibuttonrowdata} opentype="symptabs" closing=""/>
<ButtonRowTabs data={medibuttonrowdata} cla="symptabs"/>
</Collapsible>
- <H2 text="The future of CF treatment with gene therapy"></H2>
- <p> While mentioned medications have improved the quality of life for numerous CF patients, they only manage symptoms rather than cure the disease. Moreover, most of them are expensive and not world-wide accessible. Our research is focused on the development of a gene therapy that targets the underlying cause of CF by correcting the defective CFTR gene. <PreCyse/> aims to halt disease progression and reduce the treatment burden for patients."</p>
+ <H2 text="CF treatment with gene therapy"></H2>
+ <p>While mentioned medications have improved the quality of life for numerous CF patients, they only manage symptoms rather than cure the disease. Moreover, most of them are expensive and not world-wide accessible. Our research is focused on the development of a gene therapy that targets the underlying cause of CF by correcting the defective CFTR gene. <PreCyse/> aims to halt disease progression and reduce the treatment burden for patients.</p>
<img src="https://static.igem.wiki/teams/5247/charts-maps/cfper10-000.png"/>
</Subesction>
</Section>
--
GitLab